Jump to content

Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and 4-HO-DET: Difference between pages

(Difference between pages)
Page 1
Page 2
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 473150128 of page 4-HO-DET for the Chem/Drugbox validation project (updated: 'CAS_number').
 
consistent citation formatting
 
Line 1: Line 1:
{{short description|Chemical compound}}
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:4-HO-DET|oldid=473150128}} 473150128] of page [[4-HO-DET]] with values updated to verified values.}}
{{more citations needed|date=June 2013}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 413272793
| Watchedfields = changed
| IUPAC_name = 3-(2-diethylaminoethyl)-1H-indol-4-ol
| verifiedrevid = 477221917
| IUPAC_name = 3-(2-Diethylaminoethyl)-1''H''-indol-4-ol
| image = 4-HO-DET.svg
| image = 4-HO-DET.svg
| width = 140
| width = 140
| image2 = 4-HO-DET-3d-sticks.png
| image2 = 4-HO-DET-3d-sticks.png

<!--Clinical data-->
<!--Clinical data-->
| tradename =
| tradename =
Line 14: Line 16:
| legal_AU =
| legal_AU =
| legal_CA =
| legal_CA =
| legal_UK =
| legal_UK = Class A
| legal_US =
| legal_US =
| legal_status =
| legal_DE = Anlage I
| routes_of_administration =
| routes_of_administration =

<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
| bioavailability =
| bioavailability =
Line 25: Line 26:
| elimination_half-life =
| elimination_half-life =
| excretion =
| excretion =

<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = <!-- blanked - oldvalue: 22204-89-3 -->
| CAS_number = 22204-89-3
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 7E0BR15575
| ATC_prefix =
| ATC_prefix =
| ATC_suffix =
| ATC_suffix =
Line 36: Line 38:
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 143202
| ChEMBL = 143202

<!--Chemical data-->
<!--Chemical data-->
| C=14 | H=20 | N=2 | O=1
| C=14 | H=20 | N=2 | O=1
| smiles = CCN(CC)CCc1c[nH]c2cccc(O)c12
| molecular_weight = 232.32 g/mol
| smiles = Oc1cccc2c1c(cn2)CCN(CC)CC
| InChI = 1/C14H20N2O/c1-3-16(4-2)9-8-11-10-15-12-6-5-7-13(17)14(11)12/h5-7,10,15,17H,3-4,8-9H2,1-2H3
| InChIKey = OHHYMKDBKJPILO-UHFFFAOYAC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H20N2O/c1-3-16(4-2)9-8-11-10-15-12-6-5-7-13(17)14(11)12/h5-7,10,15,17H,3-4,8-9H2,1-2H3
| StdInChI = 1S/C14H20N2O/c1-3-16(4-2)9-8-11-10-15-12-6-5-7-13(17)14(11)12/h5-7,10,15,17H,3-4,8-9H2,1-2H3
Line 50: Line 48:
| melting_high = 106
| melting_high = 106
}}
}}
'''4-HO-DET''', also known as '''4-hydroxy-diethyl-tryptamine''', '''CZ-74''', is a [[Psychedelics, dissociatives and deliriants|hallucinogenic drug]] and [[Psychedelic drug|psychedelic compound]] of moderate duration. 4-HO-DET is a [[substitution reaction|substituted]] [[tryptamine]], structurally related to [[psilocin]], [[ethocybin]], and [[4-HO-DIPT]].<ref name = "Greene_2021">{{cite book | vauthors = Greene SL | chapter = Tryptamines |veditors = Dargan PI, Wood DM |title=Novel Psychoactive Substances: Classification, Pharmacology and Toxicology |date=2021 |publisher=Academic Press |location=London, United Kingdom |isbn=978-0-12-819030-2 |page=499 |edition=Second | chapter-url=https://books.google.com/books?id=8WIFEAAAQBAJ&dq=4-HO-DET&pg=PA499}}</ref>

==Analogs==
4-HO-DET is the N,N-diethyl analog of psilocin. The [[acetic acid]] [[ester]] of 4-HO-DET is known as [[4-AcO-DET]] and the [[phosphoric acid]] ester of 4-HO-DET is known as 4-phosphoryloxy-DET, CEY-19, or [[ethocybin]]. These compounds may likely be [[Prodrug|prodrugs]] of 4-HO-DET as has been shown with the acetate and phospate esters of other methylated tryptamines such as psilocin.<ref>{{Cite journal | vauthors = Nichols DE |title=Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin |date=February 11, 1999 |url=http://www.thieme-connect.de/DOI/DOI?10.1055/s-1999-3490 |journal=Synthesis |volume=1999 |issue=6 |pages=935–938 |doi=10.1055/s-1999-3490|s2cid=32044725 }}</ref>

==History==
4-HO-DET received the lab code CZ-74 in the late 1950s by the inventors of the substance, [[Albert Hofmann]] and [[Franz Troxler]]. The substance was used together with its phosphoryloxy-analog ethocybin in human clinical trials in the 1960s by the German researchers [[Hanscarl Leuner]] and G. Baer.{{citation needed|date=June 2017}} It was later explored by Alexander Shulgin in his 1997 book ''[[TiHKAL]]''.<ref>{{CiteTiHKAL}}</ref>

==Dosage==
''[[TiHKAL]]'' reports moderate effects at 10–25&nbsp;mg ingested orally.<ref name="Shulgin_1997">{{cite web |url=http://isomerdesign.com/PiHKAL/read.php?id=16&domain=tk |title=#16 4-HO-DET | vauthors = Shulgin A, Shulgin A |publisher=Transform Press |date=September 1997 |website=Isomer Design |access-date=28 November 2023}}</ref>

==Effects==
4-HO-DET produces [[Psychedelic drug|psychedelic]] effects similar to [[LSD]] and [[psilocybin]].<ref name="Shulgin_1997" />

==Legality==

===United States===
4-HO-DET is unscheduled in the United States, but purchase, sale, or possession for human consumption could be prosecuted under the [[Federal Analogue Act]].<ref>{{Cite web |title=21 U.S. Code § 841 - Prohibited acts A |url=https://www.law.cornell.edu/uscode/text/21/841 |access-date=2016-08-02 |website=LII / Legal Information Institute |mode=cs2}}</ref>

===Sweden===
[[Riksdag|''Sveriges riksdags'']] health ministry [[:sv:Statens folkhälsoinstitut|''Statens folkhälsoinstitut'']] classified 4-HO-DET as "health hazard" under the act [[:sv:Lagen om förbud mot vissa hälsofarliga varor|''Lagen om förbud mot vissa hälsofarliga varor'']] (translated ''Act on the Prohibition of Certain Goods Dangerous to Health'') as of Nov 1, 2005, in their regulation SFS 2005:733 listed as 4-hydroxi-N,N-diethyltryptamin (4-HO-DET), making it illegal to sell or possess.<ref>{{cite web | title = Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor; | trans-title = Ordinance amending the ordinance (1999: 58) on the prohibition of certain dangerous goods; | language = sv | url = http://www.notisum.se/rnp/sls/sfs/20050733.pdf | date = 6 October 2005 | work = Svensk författningssamling (Swedish Code of Statutes) | access-date = 6 September 2013 | archive-date = 26 June 2021 | archive-url = https://web.archive.org/web/20210626164247/http://www.notisum.se/rnp/sls/sfs/20050733.pdf | url-status = dead }}</ref>

==See also==
* [[TiHKAL]]
* [[Indole]]s

==References==
{{reflist}}

==External links==
* [http://www.erowid.org/library/books_online/tihkal/tihkal16.shtml TiHKAL 4-HO-DET] information at [[Erowid]]
* [http://tihkal.info/read.php?domain=tk&id=16 4-HO-DET entry in TiHKAL • info]
* [http://www.erowid.org/chemicals/4_acetoxy_det/4_acetoxy_det_article1.shtml Ethacetin degradation]

{{Hallucinogens}}
{{Tryptamines}}

[[Category:Phenols]]
[[Category:Psychedelic tryptamines]]
[[Category:Designer drugs]]
[[Category:Diethylamino compounds]]